THRB and brain cancer: Clinical observations in human astrocytomas have also shown that the expression of THRα1 and/or THRα2 tends to decrease, while the expression of THRβ1 significantly increases, thus suggesting that brain cancers might also be linked to alterations of the combination of nuclear receptors expressed [277,279].